Beam Therapeutics (NASDAQ:BEAM) is one of the most promising mid-cap healthcare stocks under $50. On December 9, H.C. Wainwright analyst Patrick Trucchio reaffirmed his bullish stance on Beam ...

Contrarius Investment Management, an investment management company, released its third-quarter investor letter for the ...

Kentucky bourbon maker Jim Beam says it won't distill bourbon at its main plant in Clermont, Kentucky, for all of 2026 because of economics and changing consumer tastes.

On Dec. 8, Civil Air Patrol observed its annual Awards Banquet at the McAllister Museum of Aviation Hangar. Approximately 160 ...

Visakhapatnam: Minimum temperatures have risen marginally in parts of Andhra Pradesh over the last few days, while early ...

What a fun season, and it’s not over, which is literally the best part! And it’s so appropriate that our final regular season ...

SNL: Watch Cher perform 'DJ Play a Christmas Song,' 'Run Rudolph Run' A restaurant announces its closure. Fans line up for ...

This industrial software stock warrants a valuation rerating, which could lead to significant share price appreciation in the ...

With a runner-tuned beam, lightweight fit, and dual-fuel battery system, it’s serious lighting for serious mileage.

Small-cap stocks could be one of the biggest stories of 2026 — and most investors aren’t paying attention yet. In this video, Bridget sits down with MarketBeat analyst Chris Markoch to break down five ...

Pernod Ricard (PDRDF/PRNDY) remains a sell as fundamentals deteriorate and no turnaround is in sight. Q1 FY26 sales were ...

The $329 million I-95 cap project will create nearly 12 acres of parkland and connect Old City to the Delaware River waterfront.